Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
about
CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.Molecular Technologies in the Clinical Diagnostic LaboratoryCurrent approaches and challenges for monitoring treatment response in colon and rectal cancerNSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer CellsA phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome3'-hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumorigenesis in colorectal cancer cells through ROS-mediated DNA damage and mitochondrial dysfunction.New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targetsPhase 1 study of OCV-C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer.p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model.Alcohol, DNA methylation, and cancerPolymorphisms of cell cycle regulator genes CCND1 G870A and TP53 C215G: Association with colorectal cancer susceptibility risk in a Malaysian populationMicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10.Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo.Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer.Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis.Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells.Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer.Glutathione S-transferase M1 null genotype related to poor prognosis of colorectal cancer.Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells.Construction of a novel vector expressing Survivin-shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells.Dihydroartemisinin induces apoptosis in colorectal cancer cells through the mitochondria-dependent pathway.Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells.Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer.Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells.4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression
P2860
Q24306296-1F09AD86-BC25-4E36-91BB-F4B0B7091D0EQ26996463-54DB6570-D235-4AEF-A728-C586A2583EAFQ27010257-C1EE6871-CE62-4242-9721-656E9DC33D38Q28546932-B4163D48-FF6F-4992-8224-9072C7E8F9AAQ33556780-38909D3A-D21E-481C-BC1E-461220A6188CQ33566829-6B2DB886-D72A-438C-A0F8-9278600B3A1BQ33731804-36F57404-FF0A-4527-B18B-4AF72104ED64Q33738883-9DB1A58B-DC61-4775-8481-DC325B4D32C1Q34008781-A2DC6AAD-9F9C-4F59-A5C9-98431DF76933Q34120400-2877FC52-1368-42CD-B806-47C9E3D46206Q34390179-EB99F6AC-C0F4-4A8E-9CE4-7028385595CAQ36335755-6ED7D4E0-FD49-4EF9-961F-4081BFE0C295Q36504323-0827B0C2-07EE-48C5-815F-5B80B3351DC6Q36546587-E6839AA8-55FC-45FF-9A9D-570581B7C1D9Q37151600-BE415CBA-FA29-4BCB-99F3-A978355663D8Q38169157-C9307EF8-76DF-4126-A502-B561A2B85783Q38430173-397B504D-192A-4574-9C09-E5A16351412FQ38558090-D0725738-3EDD-4019-A974-33A20C1968C6Q38826542-47FBE218-119F-41A7-9A61-1BF2A25AA63AQ38887255-78F929B5-7E8E-40E4-B2E6-8E1C76AEF95BQ38925268-25F44AE2-8AD6-4ADD-86E1-F94A3D4282A7Q38940597-DEB037BF-77CF-4F7A-9E2F-5EC570845729Q40907752-95B12E35-8F46-4443-A39B-412CA76A6962Q40937838-7F26FD3F-A9C3-4E10-8C48-93FAF2A4D2C2Q42108941-24B69254-0204-4DA8-8A0F-B942D7D23732Q42327896-30CF4363-05B6-4944-B81F-EBF051876871Q45875372-1CC47AAC-62A4-4A59-941D-6BF076E069EAQ46933043-5F9D0BAA-4121-416F-BA20-BC4057DCF99DQ47100299-5520C1F1-0E88-48F5-937A-7A3F9568FC1EQ49286697-070E8327-7B61-4441-9B43-EAC0ED359276Q50068040-247D3A9F-F84C-4A75-B653-3CBDC27C677FQ58789473-17DDD0DB-1287-400B-B19E-AE29811FCD9B
P2860
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
@en
type
label
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
@en
prefLabel
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
@en
P2093
P2860
P50
P1476
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
@en
P2093
Beatriz Castaño
Olga Martinez-Augustin
Oscar Briz
Rosario Del Moral-Avila
P2860
P304
P356
10.3109/03602532.2011.638303
P407
P577
2012-05-01T00:00:00Z